NDC 73648-155 - RYONCIL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73648-155
- Manufacturer
- Mesoblast | Mesoblast, Inc. | LONZA BIOLOGICS TUAS PTE. LTD. | Integrated Commercialization Solutions, LLC | WuXi Advanced Therapies Inc.
- Effective date
- 2025-09-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| RYONCIL | Mesoblast | Mesoblast, Inc. | LONZA BIOLOGICS TUAS PTE. LTD. | Integrated Commercialization Solutions, LLC | WuXi Advanced Therapies Inc. | 2025-09-11 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.